Antisense oligonucleotides: towards clinical trials

By Agrawal S.  

Trends in Biotechnology, Vol. 14, Iss. 10, 1996-10 ,pp. : 376-387

Elsevier

Access to resources Recommend Favorite

Targeting Metabolic Enzymes in Cancer – Clinical Trials Update

By  

Current Enzyme Inhibition, Vol. 9, Iss. 2, 2013-09 ,pp. : 152-160

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: Is the UK NHS a good place to do clinical trials?

By Steiner Jan  

Journal of Commercial Biotechnology, Vol. 11, Iss. 3, 2005-04 ,pp. : 205-207

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Clinical trials in the pharmaceutical industry: The scope of the research exemption under French patent law – clarification is still awaited

By Cousté M  

Journal of Commercial Biotechnology, Vol. 9, Iss. 1, 2002-09 ,pp. : 67-71

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

A brave new Europe with the introduction of the EU Clinical Trials Directive: Impact upon the pharma industry and academic research with special emphasis on pharmacovigilance

By Ladds Graeme  

Journal of Commercial Biotechnology, Vol. 11, Iss. 1, 2004-10 ,pp. : 44-53

Palgrave Macmillan Ltd

Access to resources Recommend Favorite